| 产品名称： | Human Coxsackievirus B3 |
|---|---|
| 商品货号： | TS213846 |
| Classification： | Picornaviridae, Enterovirus, Human enterovirus B |
| Deposited As： | Coxsackievirus B3 |
| Agent： | Human Coxsackievirus B3 |
| Strain： | Nancy |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 1 mL per vial |
| Storage Conditions： | -70°C or colder |
| Comments： | Cryopreserved in 10% FBS. |
| Effect on Host： | CPE, refractile rounding and sloughing |
| Recommended Host： | LLC-MK2 (ATCC® CCL-7.1™) |
| Growth Conditions： | Temperature: 37°C
Recommendations for Infection:xa0Plate cells 24-48 hours prior to infection and infect when cultures are 80-90% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 0.1). Adsorb 1-2 hours at 37°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 1-4 days
|
| Name of Depositor： | JL Melnick |
| Source： | Stool from febrile patient with minor illness, Connecticut, 1949 |
| References： | Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925 |
| Cross References： | Nucleotide (GenBank) : AJ295194 Human coxsackievirus B3 genomic RNA for partial polyprotein gene, isolate VR-30, ATCC. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Human Coxsackievirus B3 |
|---|---|
| 商品货号： | TS213846 |
| Classification： | Picornaviridae, Enterovirus, Human enterovirus B |
| Deposited As： | Coxsackievirus B3 |
| Agent： | Human Coxsackievirus B3 |
| Strain： | Nancy |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 1 mL per vial |
| Storage Conditions： | -70°C or colder |
| Comments： | Cryopreserved in 10% FBS. |
| Effect on Host： | CPE, refractile rounding and sloughing |
| Recommended Host： | LLC-MK2 (ATCC® CCL-7.1™) |
| Growth Conditions： | Temperature: 37°C
Recommendations for Infection:xa0Plate cells 24-48 hours prior to infection and infect when cultures are 80-90% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 0.1). Adsorb 1-2 hours at 37°C in a humidified 5% CO2 atmosphere, rocking every 20-30 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 1-4 days
|
| Name of Depositor： | JL Melnick |
| Source： | Stool from febrile patient with minor illness, Connecticut, 1949 |
| References： | Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925 |
| Cross References： | Nucleotide (GenBank) : AJ295194 Human coxsackievirus B3 genomic RNA for partial polyprotein gene, isolate VR-30, ATCC. |
